Definition of TCR Epitopes for CTL-Mediated Attack of Cutaneous T Cell Lymphoma 1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Immunology

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.171.5.2714PMID 12928425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids

  2004cited by this paper
• Regulatory T Cells Control Autoimmunity In Vivo by Inducing Apoptotic Depletion of Activated Pathogenic Lymphocytes1

  2003cited by this paper
• Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.

  2002cited by this paper
• Low CD7 Expression in Benign and Malignant Cutaneous Lymphocytic Infiltrates: Experience With an Antibody Reactive With Paraffin-Embedded Tissue

  2002cited by this paper
• Vaccination with Minigenes Encoding VH-derived Major Histocompatibility Complex Class I–binding Epitopes Activates Cytotoxic T Cells that Ablate Autoantibody-producing B Cells and Inhibit Lupus

  2002cited by this paper
• Cytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells

  2001cited by this paper
• Serological detection of cutaneous T-cell lymphoma-associated antigens.

  2001cited by this paper
• PAProC: a prediction algorithm for proteasomal cleavages available on the WWW

  2001cited by this paper
• Mimotopes for tumor‐specific T lymphocytes in human cancer determined with combinatorial peptide libraries

  2001cited by this paper
• Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

  2000influential reference
• On the dynamics of TCR:CD3 complex cell surface expression and downmodulation.

  2000cited by this paper
• Preferential Recognition of TCR Hypervariable Regions by Human Anti-Idiotypic T Cells Induced by T Cell Vaccination1

  2000cited by this paper
• Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma.

  2000cited by this paper
• Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines.

  1999cited by this paper
• SYFPEITHI: database for MHC ligands and peptide motifs

  1999influential reference
• TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response.

  1999cited by this paper
• CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.

  1999cited by this paper
• Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma

  1999cited by this paper
• DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection.

  1999cited by this paper
• First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites.

  1998cited by this paper
• Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma.

  1998cited by this paper
• Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma

  1998cited by this paper
• Tumour‐specific cytotoxic T lymphocyte activity in Th2‐type Sézary syndrome: its enhancement by interferon‐gamma (IFN‐γ) and IL‐12 and fluctuations in association with disease activity

  1998cited by this paper
• Cutaneous T-cell lymphomas.

  1998cited by this paper
• Tumor‐specific peptides in cutaneous T‐cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T‐cell receptor

  1998influential reference
• Cytosolic Degradation of T-cell Receptor α Chains by the Proteasome*

  1997cited by this paper
• Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

  1997cited by this paper
• The alpha chain of the T cell antigen receptor is degraded in the cytosol.

  1997cited by this paper
• EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

  1997cited by this paper
• TCR vaccines for active immunotherapy of T cell malignancies.

  1997cited by this paper
• The α Chain of the T Cell Antigen Receptor Is Degraded in the Cytosol

  1997cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens.

  1996cited by this paper
• Human CD8+ T lymphocyte clones specific for T cell receptor V beta families expressed on autologous CD4+ T cells.

  1995cited by this paper
• Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule.

  1995cited by this paper
• The use of Epstein-Barr virus-transformed B lymphocyte cell lines in a peptide-reconstitution assay: identification of CEA-related HLA-A*0301-restricted potential cytotoxic T-lymphocyte epitopes.

  1995cited by this paper
• An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301.

  1995cited by this paper
• Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

  1994cited by this paper
• T-cell activation-associated antigen expression by neoplastic T-cells.

  1992cited by this paper
• Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

  1987cited by this paper
• Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results.

  1987cited by this paper
• Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence.

  1986cited by this paper
• Cutaneous T cell lymphoma associated with recurrent panniculitis and reactive histiocytosis.

  1981cited by this paper

• Immunobiology and treatment of cutaneous T-cell lymphoma

  2024cites this paper
• mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma

  2021cites this paper
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication.

  2020cites this paper
• Amendment history : Corrigendum ( March 2007 ) Immunopathogenesis and therapy of cutaneous T cell lymphoma

  2018cites this paper
• Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides.

  2013cites this paper
• Immune functions of the skin.

  2011cites this paper
• Molecular markers associated with clinical response to bexarotene therapy in cutaneous T-cell lymphoma.

  2011cites this paper
• Cutaneous T-Cell Lymphoma: Mycosis Fungoides/Sézary Syndrome: Part 1

  2011cites this paper
• Cutaneous T-Cell Lymphoma: Mycosis Fungoides/Sézary Syndrome, Part 2

  2011cites this paper
• The role of idiotype-specific immunity in antigen receptor diversity

  2010cites this paper
• Detergent fractionation with subsequent subtractive suppression hybridization as a tool for identifying genes coding for plasma membrane proteins

  2009cites this paper
• Cutaneous T Cell Lymphoma Patients T Cells + Expression and Function in CD 8 Down-Modulation of CXCR 3 Surface

  2007cites this paper
• Down-Modulation of CXCR3 Surface Expression and Function in CD8+ T Cells from Cutaneous T Cell Lymphoma Patients1

  2007cites this paper
• Transimmunization for cutaneous T cell lymphoma: A phase I study

  2006cites this paper
• Identification of HLA class I dependent immunogenic peptides from clonotypic TCRβ expressed in cutaneous T‐cell lymphoma

  2006cites this paper
• Evidence for restricted Vbeta usage in the leukemic phase of cutaneous T cell lymphoma.

  2005cites this paper
• Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.

  2005cites this paper
• Immunopathogenesis and therapy of cutaneous T cell lymphoma.

  2005cites this paper
• Evidence for restricted Vβ usage in the leukemic phase of cutaneous T cell lymphoma

  2005cites this paper
• The pathogenesis of mycosis fungoides.

  2004cites this paper
• Immunological Strategies to Fight Skin Cancer

  2004cites this paper
• Cutaneous T-cell lymphoma.

  2004cites this paper
• Cutaneous T-cell lymphoma : malignant proliferation of T-regulatory cells

  2004cites this paper
• Anti‐tumor immune responses and tumor regression induced with mimotopes of a tumor‐associated T cell epitope

  2003cites this paper
• Journal of Immune Based Therapies and Vaccines Rapid Construction of a Dendritic Cell Vaccine through Physical Perturbation and Apoptotic Malignant T Cell Loading Background

  year unknowncites this paper